SBIR Phase I: Development of a Novel Mammalian Cell-Based Nano-Biological Coating for Impl — NSF Award to NOVAURUM BIOSCIENCES INC
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to address the critical health and economic burden associated with implant-related infections by reducing or eliminating them with a novel biocompatible and antimicrobial nano-biological coating on implants. Inf
| Award title | SBIR Phase I: Development of a Novel Mammalian Cell-Based Nano-Biological Coating for Impl |
|---|---|
| Award ID | 2449177 |
| Awardee | NOVAURUM BIOSCIENCES INCORPORATED |
| City | SOMERVILLE |
| State | MA |
| Amount obligated | $305,000 |
| Principal investigator | Thomas Webster |
| Program | SBIR Phase I |
| Start date | 03/01/2025 |
| Abstract | The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to address the critical health and economic burden associated with implant-related infections by reducing or eliminating them with a novel biocompatible and antimicrobial nano-biological coating on implants. Infections related to implanted medical devices are shockingly common, as one million implant-related infections occur each year in the United States. These infections are usually tre |
| Source | NSF Awards |
$799/mo
Try NSFGrants →